Global Health Limited (ASX:GLH)
Australia · Delayed Price · Currency is AUD 0.0650
-0.0040 (-5.80%)
Jul 29, 2026, 2:47 PM AEST
Global Health Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 4 | 4 | 7 | 8 | 13 | 24 | |
Market Cap Growth | -8.11% | -42.82% | -11.04% | -39.90% | -44.62% | 186.58% |
Enterprise Value | 4 | 4 | 6 | 5 | 6 | 23 |
Last Close Price | 0.07 | 0.07 | 0.12 | 0.14 | 0.23 | 0.47 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PS Ratio | 0.45 | 0.46 | 0.81 | 1.00 | 1.99 | 3.35 |
PB Ratio | -0.88 | -1.07 | -2.40 | -4.83 | 2.14 | 5.82 |
P/TBV Ratio | - | - | - | - | 5.03 | 21.78 |
P/FCF Ratio | - | - | - | - | - | 17.17 |
P/OCF Ratio | - | - | - | - | - | 17.17 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 0.52 | 0.41 | 0.69 | 0.59 | 0.95 | 3.29 |
EV/EBITDA Ratio | - | - | - | - | - | 26267.36 |
EV/FCF Ratio | - | - | - | - | - | 16.85 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | -0.37 | -0.39 | -0.35 | -0.03 | 0.02 | 0.08 |
Debt / EBITDA Ratio | - | - | - | - | - | 1.53 |
Debt / FCF Ratio | - | - | - | - | - | 0.22 |
Net Debt / Equity Ratio | -0.14 | -0.02 | 0.36 | 1.36 | -1.02 | -1.12 |
Net Debt / EBITDA Ratio | -0.85 | -0.10 | 0.85 | 0.59 | 3.16 | -5160.64 |
Net Debt / FCF Ratio | -1.85 | -0.11 | 0.90 | 0.63 | 5.24 | -3.31 |
Asset Turnover | 3.97 | 2.93 | 2.80 | 1.11 | 0.65 | 0.90 |
Quick Ratio | 0.26 | 0.46 | 0.56 | 0.61 | 1.43 | 1.15 |
Current Ratio | 0.40 | 0.53 | 0.60 | 0.66 | 1.49 | 1.19 |
Return on Equity (ROE) | - | - | - | -360.64% | -40.47% | -18.80% |
Return on Assets (ROA) | -20.77% | -16.94% | -24.72% | -32.94% | -12.31% | -0.09% |
Return on Invested Capital (ROIC) | - | - | - | - | - | -2.86% |
Return on Capital Employed (ROCE) | 22.50% | 31.70% | 60.20% | 237.10% | -31.80% | -0.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | -21.17% | -21.76% | -18.84% | -102.86% | -15.73% | -2.07% |
FCF Yield | -8.39% | -17.74% | -16.51% | -44.33% | -9.13% | 5.83% |
Buyback Yield / Dilution | -0.78% | -0.27% | -0.92% | -2.71% | -32.20% | -8.50% |